Digital Angel Corporation, VeriChip and RECEPTORS LLC Publish White Paper for Self-Contained Implantable RFID Glucose-Sensing Microchip

SO. ST. PAUL, Minn. & DELRAY BEACH, Fla.--(BUSINESS WIRE)--Digital Angel Corporation ("Digital Angel") (AMEX: DOC), an advanced technology company in the field of rapid and accurate identification, location tracking and condition monitoring of high-value assets, VeriChip Corporation (“VeriChip”) (NASDAQ: CHIP), a provider of RFID systems for healthcare and patient-related needs, and their development partner, RECEPTORS LLC, announced today the companies have published a white paper entitled “Development of an Implantable Glucose Sensor” discussing development plans for a self-contained implantable RFID glucose-sensing microchip. Upon completion, the in vivo glucose-sensing microchip will be the first device able to measure glucose levels in the human body and be read with an external reader.